Skip to main content

Table 2 Long term cardiac events

From: Red blood cell distribution width as long-term prognostic markers in patients with coronary artery disease undergoing percutaneous coronary intervention

Clinical outcomes

Low RDW (n = 2894)

High RDW (n = 3152)

P value

Primary end point

 Long-term mortality, n (%)

113 (3.9%)

196 (6.2%)

< 0.0001

Secondary endpoints

 Stroke, n (%)

35 (1.2%)

47 (1.5%)

0.344

 Readmission, n (%)

360 (12.4%)

459 (14.6%)

0.016

 MACEs, n (%)

317 (11.0%)

468 (14.8%)

< 0.0001

 MACCEs, n (%)

351 (12.1%)

511 (16.2%)

< 0.0001

 Cardiac death, n (%)

88 (3.0%)

163 (5.2%)

< 0.0001

 Stroke, n (%)

35 (1.2%)

47 (1.5%)

0.344

 Bleeding events, n (%)

76 (2.6%)

99 (3.1%)

0.233

 Re-stent implantation

118 (4.1%)

143 (4.5%)

0.380

 Recurrent MI, n (%)

79 (2.7%)

115 (3.6%)

0.043

  1. MACCEs main adverse cardiovascular and cerebrovascular events, MACEs major adverse cardiac events, Recurrent MI recurrent myocardial infarction